Logo image of ALSPW.PA

SPINEWAY (ALSPW.PA) Stock Fundamental Analysis

EPA:ALSPW - FR001400N2P2 - Common Stock

0.1272 EUR
0 (-2.9%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

ALSPW gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 57 industry peers in the Health Care Equipment & Supplies industry. While ALSPW seems to be doing ok healthwise, there are quite some concerns on its profitability. ALSPW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALSPW had negative earnings in the past year.
ALSPW had a positive operating cash flow in the past year.
In the past 5 years ALSPW always reported negative net income.
In the past 5 years ALSPW always reported negative operating cash flow.
ALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ALSPW has a Return On Assets of -6.29%. This is in the lower half of the industry: ALSPW underperforms 66.67% of its industry peers.
The Return On Equity of ALSPW (-7.96%) is worse than 64.91% of its industry peers.
Industry RankSector Rank
ROA -6.29%
ROE -7.96%
ROIC N/A
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPW.PA Yearly ROA, ROE, ROICALSPW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

Looking at the Gross Margin, with a value of 71.33%, ALSPW belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
ALSPW's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALSPW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
ALSPW.PA Yearly Profit, Operating, Gross MarginsALSPW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

5

2. Health

2.1 Basic Checks

ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALSPW has more shares outstanding
Compared to 5 years ago, ALSPW has more shares outstanding
ALSPW has a better debt/assets ratio than last year.
ALSPW.PA Yearly Shares OutstandingALSPW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALSPW.PA Yearly Total Debt VS Total AssetsALSPW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ALSPW has an Altman-Z score of 0.86. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.
ALSPW's Altman-Z score of 0.86 is on the low side compared to the rest of the industry. ALSPW is outperformed by 68.42% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that ALSPW is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, ALSPW belongs to the best of the industry, outperforming 85.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACC4.18%
ALSPW.PA Yearly LT Debt VS Equity VS FCFALSPW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALSPW has a Current Ratio of 3.19. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.
ALSPW has a Current ratio of 3.19. This is amongst the best in the industry. ALSPW outperforms 89.47% of its industry peers.
ALSPW has a Quick Ratio of 2.04. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.04, ALSPW belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.04
ALSPW.PA Yearly Current Assets VS Current LiabilitesALSPW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.85% over the past year.
ALSPW shows a decrease in Revenue. In the last year, the revenue decreased by -5.46%.
Measured over the past years, ALSPW shows a quite strong growth in Revenue. The Revenue has been growing by 18.95% on average per year.
EPS 1Y (TTM)99.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.92%
Revenue 1Y (TTM)-5.46%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%-14.72%

3.2 Future

ALSPW is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -41.47% yearly.
ALSPW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.08% yearly.
EPS Next Y-100.14%
EPS Next 2Y-41.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALSPW.PA Yearly Revenue VS EstimatesALSPW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALSPW.PA Yearly EPS VS EstimatesALSPW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 -5M -10M -15M -20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPW. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPW.PA Price Earnings VS Forward Price EarningsALSPW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.1
ALSPW.PA Per share dataALSPW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

ALSPW's earnings are expected to decrease with -41.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSPW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPINEWAY

EPA:ALSPW (9/5/2025, 7:00:00 PM)

0.1272

0 (-2.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-14 2025-10-14
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap105.58K
Analysts86.67
Price Target0.37 (190.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.86%
PT rev (3m)2.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-800%
EPS NY rev (3m)-800%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.18
P/B 0
P/tB 0.01
EV/EBITDA -2.1
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)0.7
OCFY550.31%
SpS13.24
BVpS28.75
TBVpS17.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.29%
ROE -7.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.33%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 1.36
Cap/Depr 118.69%
Cap/Sales 12.83%
Interest Coverage N/A
Cash Conversion 51.42%
Profit Quality N/A
Current Ratio 3.19
Quick Ratio 2.04
Altman-Z 0.86
F-Score6
WACC4.18%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.92%
EPS Next Y-100.14%
EPS Next 2Y-41.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.46%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%-14.72%
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y97.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y121.03%
OCF growth 3YN/A
OCF growth 5YN/A